SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is experiencing a surge in social sentiment driven by speculative retail interest and community members hoping for a turnaround after recent historical declines. Discussions center on its long-term potential, with bulls looking for breakout signals while others caution against the volatility of the asset.

ElizaOS

ElizaOS is facing intense community polarization, with critics alleging widespread internal manipulation and fraud, while proponents remain optimistic about the project's long-term utility as a cross-chain AI agent system. The intense discourse is fueled by recent volatility, migration activities, and conflicting expectations regarding potential market rallies versus claims of systemic corruption.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing high speculative interest and increased trading volume, driven by community enthusiasm for its data economy narrative and long-term IoT utility. While some investors remain cautious about the lack of official major corporate partnership announcements, active traders are focused on technical breakout patterns and potential ecosystem expansion.

TOSHI

TOSHI is attracting renewed community attention as holders anticipate potential ecosystem catalysts, including rumors of exchange listings and new tool integrations that could drive utility and deflationary pressure. Investors are actively discussing the token's accumulation phase and potential for a breakout, with many viewing the current price as a long-term entry point.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending as investors digest significant institutional shifts, including a recent Uber stake filing and continued share buybacks, while the company scales autonomous vehicle deployments alongside a robust pipeline of WePilot ADAS integration. Community discussion centers on WeRide's competitive positioning in international markets like the UAE and Singapore, contrasting its multi-platform scaling strategy against broader sector volatility.

Six Flags Entertainment Corp. engages in operating amusement parks in North America. It operates amusement parks, water parks, and resorts. The company is headquartered in Charlotte, NC.

Six Flags Entertainment Corp.

Six Flags Entertainment Corp

Six Flags Entertainment is trending as investors digest the recent merger between Cedar Fair and Six Flags, while also monitoring activist investor pressure to potentially unlock value through real estate monetization or strategic asset sales. The community remains focused on the company's high debt levels, ongoing leadership changes, and the impact of seasonal attendance trends on the path to long-term profitability.

NEOS ETF Trust - NEOS Bitcoin High Income ETF

NEOS Bitcoin High Income ETF

Investors are actively debating the long-term viability of the NEOS Bitcoin High Income ETF, with many community members using its high monthly yield to accumulate shares during periods of Bitcoin price consolidation. While some express concerns regarding NAV decay and the impact of the fund's covered call strategy on capital appreciation, others view the distributions as a strategic way to generate passive income while maintaining exposure to Bitcoin's long-term potential.

Fluor Corp. is a holding company, which engages in the provision of engineering, procurement and construction (EPC), fabrication and modularization, and project management services. It operates through the following segments: Energy Solutions, Urban Solutions, Mission Solutions, and Other. The Energy Solutions segment focuses on energy transition markets, asset decarbonization, carbon capture, renewable fuels, waste-to-energy, green chemicals, hydrogen, nuclear power, and other low-carbon energy sources. The Urban Solutions segment involves the provision of EPC, project management, and professional staffing services. The Mission Solutions segment includes the technical products to federal agencies and services to commercial nuclear clients. The Other segment consists of operations on AMECO, Stork and NuScale. The company was founded by John Simon Flour, Sr. in 1912 and is headquartered in Irving, TX.

Fluor Corporation

Fluor Corporation is experiencing significant investor interest driven by its substantial contract pipeline in energy infrastructure, data centers, and industrial projects, alongside optimism regarding its strategic ownership in nuclear energy technology. The community is actively debating the company's valuation, backlog execution, and the long-term potential for a rebound in its core construction and engineering business.

NICE Ltd. engages in the provision of enterprise software solutions and services. It operates through the following segments: Customer Engagement, and Financial Crime and Compliance Solutions. The Customer Engagement segment provides suites such as compliance and risk, workforce optimization, operational efficiency, customer experience, and sales and retention. The Financial Crime and Compliance Solutions segment includes embedded-AI solutions that identify risks and help prevent money laundering and fraud, as well as help ensure financial markets compliance in real-time. The company was founded on September 28, 1986 and is headquartered in Raanana, Israel.

NICE Ltd - ADR

NICE Systems Ltd.

NICE Systems is experiencing significant volatility following an earnings report that beat expectations but triggered a sell-off due to investor disappointment with forward guidance and the recent CEO transition. The community is sharply divided, with some investors viewing the price drop as a manipulation-driven buying opportunity given the company's strong fundamentals and AI-focused growth, while others are frustrated by the stock's persistent underperformance and lack of retail interest.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant attention as it scales its sovereign cloud infrastructure, highlighted by a high-profile Memorandum of Understanding with the Pakistan Digital Authority to establish national cloud engines. Investors and community members are actively debating the network's potential to compete with Big Tech providers by enabling decentralized, tamper-proof AI and cloud applications while monitoring upcoming tokenomic milestones like 'Mission 70' for potential deflationary pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 PR Newswire SALT LAKE CITY, May 7, 2026...

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

Lipocine (LPCN) delivered earnings and revenue surprises of -5.88% and +19.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of -150.00% and +0.06%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Lipocine (NASDAQ:LPCN) Director Buys $81,200.00 in Stock

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) Director John Higuchi bought 40,000 shares of the firm's stock in a transaction dated Tuesday, April 7th. The stock was purchased at an average cost of...

Mahesh Patel Purchases 25,000 Shares of Lipocine (NASDAQ:LPCN) Stock

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) CEO Mahesh Patel purchased 25,000 shares of Lipocine stock in a transaction that occurred on Monday, April 6th. The shares were bought at an average cost...

What's Going On With Lipocine Stock On Monday?

Lipocine stock rebounds after a steep drop as LPCN 1154 misses the Phase 3 endpoint, with encouraging subgroup data.read more...

Insider Buying: Lipocine (NASDAQ:LPCN) CEO Purchases 25,000 Shares of Stock

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) CEO Mahesh Patel purchased 25,000 shares of the company's stock in a transaction that occurred on Thursday, April 2nd. The shares were acquired at an average cost of $2.02 per share, with a total value of $50,500.00. Following the completion of the...

<ul class="summary-bullets"><li>While the trial failed its primary endpoint of significant reduction in depression severity, the drug was well tolerated and demonstrated a favorable safety profile, the company said.&nbsp;</li><li>Lipocine, however, said that it has identified signals in a post hoc analysis that could indicate a potential development path for LPCN 1154.</li><li>The company said it will preserve capital and engage with shareholders to evaluate all options available to the company going forward.</li></ul>Shares of Lipocine Inc. (LPCN) fell 78% on Thursday after the company said that its experimental drug LPCN 1154 did not bring about a significant reduction in the severity of postpartum depression in a trial.While the trial failed its primary endpoint of significant reduction in depression severity, the drug was well tolerated and demonstrated a favorable safety profile enough to support outpatient administration without the need for healthcare provider monitoring, the company said. No treatment-related severe or serious adverse events were reported and no cases of excessive sedation or loss of consciousness were observed, it added.<h2 class="st-heading-2">What’s Next For Lipocine?</h2>Lipocine, however, said that it has identified signals in a post hoc analysis that could indicate a potential development path for LPCN 1154. The company has applied for breakthrough therapy and fast track designations for LPCN 1154 in patients with postpartum depression based on the post hoc analysis results, the company said.While it waits for the FDA to get back, the company said it will preserve capital and engage with shareholders to evaluate all options available to the company going forward, including continued development of LPCN 1154, development of other product candidates, strategic transactions, partnerships, and other opportunities, it said.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around LPCN rose from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.A Stocktwits user drew focus to the company’s remaining pipeline, which includes experimental drugs for the treatment of non-alcoholic steatohepatitis, for the management of symptoms associated with cirrhosis and another for the prevention of recurrent preterm birth.<stembedurl>https://www.stocktwits.com/Boknow/message/649308142</stembedurl>Another user expressed hopes for a minor recovery after the crash. &nbsp;<stembedurl>https://www.stocktwits.com/Ruttobillions/message/649292640</stembedurl><a href="https://stocktwits.com/symbol/LPCN">LPCN stock</a> has dropped 37% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sgml-stock-soars-on-100-m-bank-guarantee-retail-says-one-last-hurdle-is-behind/cZ7xCWQRI8Z">SGML Stock Soars On $100M Bank Guarantee, Retail Says 'One Last Hurdle' Is Behind</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Lipocine is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

LPCN Stock Crashes 78%— Here’s Why 

Lipocine said that its experimental drug LPCN 1154 did not bring about a significant reduction in the severity of postpartum depression in a trial.

Equity

Lipocine said that its experimental drug LPCN 1154 did not bring about a significant reduction in the severity of postpartum depression in a trial.


Lipocine Stock Tanks 78% After Phase 3 Oral Brexanolone Trial Failed To Meet Primary Endpoint

(RTTNews) - Shares of Lipocine Inc. (LPCN) are falling about 78 percent on Thursday morning trading following the announcement of topline results from its Phase 3 placebo-controlled trial, which failed to meet the primary endpoint. The trial evaluated LPCN 1154 or oral brexanolon...

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with...

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

LPCN
Lipocine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LPCN News

LPCNLipocine Inc